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Abstract
Background: Despite being the fastest growing and the most cognitively impaired age group, the oldest olds are
under-represented in clinical research. The purpose of this study was to describe the design, methods, and
baseline characteristics of the survey population and investigate possible differences in demographic, cognitive,
functional, and behavioral characteristics between oldest old with and without any performance on cognitive tests
and between oldest old alive and those deceased prior to the interview.
Methods: The Monzino 80-plus Study is a prospective door-to-door population-based survey among 80 years or
older residents in the municipalities in the province of Varese, Italy. Dementia cases were identified with a one-
phase design. Trained psychologists interviewed both the subject and a proxy informant. The interview included a
comprehensive standardized questionnaire together with an array of rating scales and a multidomain cognitive
battery to assess cognitive and functional ability, behavioral disturbances and mood.
Results: Information was available for 2,139 of the 2,428 registered individuals aged 80 years or older. Main
baseline characteristics of the population are reported and discussed. In comparison with those living, elderly
persons who had died before the first visit were older, had twice the rate of institutionalization, poorer cognitive
performance and competence, and significantly greater instrumental and basic functional disability. The percentage
of elderly persons, alive at baseline, without Mini-Mental State Examination rose rather evenly with age. Moreover,
they had significantly worse cognitive competence and functional ability, and reported higher prevalences of
depressive symptoms and problem behaviors than those with Mini-Mental State Examination.
Conclusions: Prospective investigation of a large population of oldest old can contribute significantly to
understanding the relations between age, cognitive decline, and dementia occurrence. Use of informant-based
instruments in surveys in the oldest old is crucial in assessing everyday functioning and changes, especially in
participants with no cognitive test performance available. Failure to include information on deceased elderly would
underestimate, increasingly with age, the prevalence of cognitive and functional disability in the elderly population.
Background
Cognitive functioning declines with advancing age.
Though the large majority of dementia sufferers are
among the oldest old [1,2], “patients with dementia that
are included in clinical research are systematically
younger than patients in the general population” [3].
This over-representation of individuals below age 70
and under-representation of those 80 years or older
results in an age gap that may be an important source
of bias [3]. In the near future this age gap will become
even wider since, with the continuous ageing of the
population, individuals 80 years or older are the fastest
growing segment of the elderly population [2,4].
Conducting studies in the oldest old is a major pro-
blem in epidemiological research and the number of
over-eighties investigated in surveys on dementia is
usually small [2,5]. Prevalence studies carried out in
Italy have shown a large disproportion between the
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affected by dementia were 80 years or older, the elderly
of the same age group investigated were less than 20
percent, even less than the individuals younger than 60
[2]. Due to these small numbers, prevalence and inci-
dence estimates in the oldest old fluctuate widely and
the evidence is often insufficient to reach confident con-
clusions. In addition, difficulties with the diagnoses of
dementia syndrome and type are positively associated
with age. Accordingly, the relationship between neuro-
pathological findings and dementia has also been shown
to vary with age [6-8].
Accurate estimates of dementia occurrence in this age
group are critical for a better understanding of cognitive
decline and dementia and for planning medical care. The
Monzino 80-Plus Study was established to estimate the
prevalence, incidence and progression of dementia and
cognitive impairment and to investigate their determi-
nants in the very old (80-plus) in a population-based set-
ting. Even though disease and disability are highly
prevalent among the oldest old and form the background
against which cognitive decline occurs, information on
the health status of this age segment from large cohorts
of the elderly population is lacking. Here, we describe the
study design, methods, and baseline characteristics of the
study population and address important methodological
issues in performing epidemiological studies in the very
old, such as possible differences in demographic, cogni-
tive, functional, and behavioral characteristics between
oldest old with and without any cognitive test perfor-
mance and between oldest old alive and those deceased
at the time of the interview.
Methods
Study population and setting
The Monzino 80-plus Study is an ongoing, prospective
door-to-door population-based survey among all resi-
dents 80 years or older in eight neighboring municipali-
ties in the province of Varese, Italy (Figure 1). Some
114,000 people reside (2009) in this predominantly
urban area, which was traditionally industrial (textile
and mechanical industry), though also rural when the
present study cohort was of working age. At present
employment is mainly in the industrial and service sec-
tors. Migration from other world regions is recent and
mostly involves young people, so all but six elderly peo-
p l ei n c l u d e di nt h es t u d y( t h r e eF r e n c h ,t w oG e r m a n ,
and one Albanian mother tongue but all speaking Italian
fluently) were of Italian origin. The study population
was composed mainly of local natives (64.7%) and
elderly from the same Lombardy region (8.2%), but
there were earlier immigrants from northeastern
(14.1%), northwestern (2.3%), central (2.2%), and south-
ern (7.4%) Italy. Because of the age group investigated,
the stability of the study population is high and its age
structure similar to that of the general Italian elderly
population.
Study design
Lists of residents were obtained from the municipal regis-
try offices where births and deaths are officially recorded.
All registered individuals 80 years or older residing in Cas-
tellanza, Gorla Maggiore, Gorla Minore, Marnate, Olgiate
Olona, and Solbiate Olona and 85 years or older residing
in Fagnano Olona on the prevalence day (February 12,
2002) were eligible for the study. To increase the number
of very old people and consequently the confidence in the
distributions, the survey was subsequently extended to all
registered individuals aged 90 or older residing in Galla-
rate on January 1, 2005 and, recently, to all those aged 100
or older residing in the remaining municipalities of the
province of Varese in 2009 (n = 272). In view of the small
number of men in the age group 95-99, the study was
further extended to include a random sample (n = 110) of
men aged 95-99, residents in the same municipalities as
the centenarians in the first nine months of 2010. No
exclusion criteria were used other than age and residence.
Figure 1 Map of the study area of the Monzino 80-plus Study:
A. Europe, Italy (in grey) and, within the borders of the Lombardy
region, the province of Varese (in black). B. The study area: the
province of Varese (in grey) and the area of the eight municipalities
initially investigated: in red Gallarate and in orange the seven
municipalities of the lower Olona valley (Fagnano Olona, Gorla
Maggiore, Solbiate Olona, Gorla Minore, Olgiate Olona, Marnate, and
Castellanza)
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aims were described in local newspaper articles and on
radio programs. The study protocol was explained and
discussed in meetings with local councillors, general
practitioners (GPs) and local health authorities, and the
resident population.
An introductory letter describing the survey was sent to
all eligible residents, who were contacted by phone one
to two weeks later to ascertain their intention to partici-
pate. Initial interviews took place between February 2002
and February 2004 for residents in the seven municipali-
t i e so ft h el o w e rO l o n av a l l e y( t h eo r a n g ea r e ai nF i g u r e
1B), between January 2005 and January 2006 for residents
in Gallarate, and between January and December 2009
for the centenarians residing in the other municipalities
of the province of Varese. Men 95-99 years old residing
in these latter municipalities were interviewed during the
first six months of 2010.
Because of the advanced age, frailty and indisposition to
move of the population investigated and to avoid potential
bias in estimating dementia prevalence, we skipped the
screening phase and opted for a one-phase study design
trying to gather all the information for the entire study
population at first home visit. When present, a proxy
informant (usually a family member for persons living at
home) was interviewed as well. Thus, at first visit, psychol-
ogists specifically trained for the survey collected informa-
tion about participants’ lifestyle, habits, medical history
a n dh e a l t hs t a t u sf r o mb o t ht h es u b j e c ta n dt h ep r o x y
informant who was also asked to rate the individual’s
everyday cognitive ability and functional disability, beha-
vioral disturbances, as well as the stress associated with
caregiving and the economic burden associated with the
elderly person’s health conditions. When the elderly per-
son was not in physical or mental condition to answer the
questionnaire, all the information was gathered from the
proxy informant. During the same visit, testable partici-
pants were also administered a multidomain cognitive test
battery.
Since dementia has been associated with shorter survi-
val and the probability of dying at the oldest ages is very
high, information on all aspects of the resident elderly
who died after the prevalence day but before interview
was collected from a proxy using the full questionnaire
(except, of course, for the cognitive battery) and, for
individuals in nursing homes, also from the institution’s
records. All aspects investigated refer to the time pre-
ceding death; modifications which arose as a conse-
quence of a possible critical phase preceding death were
not taken into consideration. In order to minimize attri-
tion bias, the same was done at follow-ups for partici-
pants who died between two successive visits but at
least six months after the last interview.
All participants were asked by the psychologists to
agree to blood and urine tests. Samples were taken in a
subsequent visit from consenting participants by a
trained registered nurse or doctor at home or in the
nursing home for institutionalized individuals.
To assist in the differential diagnosis of dementias,
individuals with a preliminary diagnosis of dementia or
suspected dementia were then asked to undergo a physi-
cal and complete neurological examination, if not
already done, in their place of residence by skilled neu-
rologists with broad experience in the diagnosis of
dementias and specifically trained for the study. When
needed but still not available, the neurologist proposed
that the subject undergo a brain imaging study. The
same schedule was repeated at each follow-up.
Comprehensive questionnaire
The standardized questionnaire administered at home
by the trained psychologists included information on
demographic characteristics, educational and occupa-
tional history, socioeconomic status, social relationships,
hobbies, leisure activities and interests, nutritional life-
style, habits (smoking, alcohol, coffee and tea consump-
tion, physical activity and exercise), exposure to
environmental risk factors, family medical history (with
particular emphasis on central nervous system diseases),
past and present medical history, previous use of certain
drug classes (anti-inflammatory agents, statins, H2
antagonists, estrogens, and “memory enhancers”), cur-
rent drug use (with inspection of the drug packages),
use of health services over the past year (hospital admis-
sion, emergency room, medical and instrumental investi-
gations), assistance and supervision needs, invalidity and
mobility allowance. Any medical record presented by
the subject was transcribed in the questionnaire.
Reported medical histories were compared and substan-
tiated with, when available, the information gathered
from GPs or geriatricians for the institutionalized elderly
and from the clinical records of the three Alzheimer’s
disease Evaluation Units (AEUs are clinical centers qua-
lified for the diagnosis and free-of-charge pharmacologi-
cal treatment of Alzheimer’s disease) located in the
surveyed area. All medical information available is
reviewed in the coordinating center.
Interview lasted two hours (SD 41 minutes) on average:
about two hours and 20 minutes when the neuropsycholo-
g i c a lb a t t e r yc o u l db ea d m i n i s t e r e da n do n ea n dah a l f
hours when it could not. The trustworthiness of the inter-
view (i.e. the cooperativeness, consistency, confidence, etc.
of the participants in reporting the information) was rated
by the psychologist on a 5-point scale: “very good’”,
“good”, “sufficient”, “insufficient”,a n d“difficult to evalu-
ate”. At baseline, interviews were rated as “good” or “very
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“insufficient”.
The reliability of the questionnaire had previously been
investigated, showing high agreement: Cohen’skw a s
between 0.84 and 0.93 [9,10]. To control for possible bias
in reporting drug use, data on cholinesterase inhibitor
use from the present study were compared with those
from National Health Service drug prescriptions from the
same area and period of the prevalence study: National
Health Service data gave almost identical results to those
from the present survey [11].
Measurements
All tests and scales used are widely employed measures
with good validity and reproducibility. They were admi-
nistered and scored by the specifically trained psycholo-
gists following standardized criteria detailed in the
instruction manual. All scores are centrally re-assessed.
Cognitive performance and competence
T h eM i n i - M e n t a lS t a t eE x a m i n a t i o n( M M S E )i sab r i e f
screening instrument designed to assess global cognitive
performance [12]. The Italian version used here [13] was
standardized in a cognitively normal elderly Italian popu-
lation [14] and shows high test-retest reliability (n = 318,
r = 0.89) [15]. In subjects with severe dementia but still
testable, the Severe MMSE [16] was administered. Elderly
persons with a very low educational level, serious visual
deficits, or manually impaired were administered the
Blessed Information Memory Concentration test (BIMC)
[17,18], a brief mental status test similar to the MMSE
but with no visual or manual tasks and that can be admi-
nistered also to the illiterate. BIMC as well has excellent
test-retest reliability as assessed in a previous study (r =
0.90, n = 765) [authors’ unpublished data]. A set of neu-
ropsychological tests assessing several aspects of cogni-
tion was also administered to the testable elderly: Verbal
Fluency ("Animal Category”) to evaluate verbal produc-
tion, semantic memory, and language; the Modified Bos-
ton Naming Test (15-items) to measure visual naming
skills; the Word List Memory task to assess the ability to
remember newly learned information (a list of ten
words); the Word List Recall to evaluate delayed recall
and the Word List Recognition for delayed recognition of
the ten words previously presented in the Word List
Memory task; Constructional Praxis to measure visuos-
patial and constructional abilities and Recall of Construc-
tional Praxis to assess visual memory. All these tests are
from the CERAD battery [19] and have been previously
standardized in a cognitively normal elderly Italian popu-
lation [14]. Furthermore, the Clock-drawing test was
administered following the CERAD protocol to explore
visuo-spatial, constructional, and executive functions; the
P r o s eM e m o r yt e s tt om e a s u r et h ei m m e d i a t ea n d
delayed recall of a short story [20,21]; the Visual Search
on Matrices of Digits (score range: 0-60) to test selective
and sustained attention [20]. The Trail Making Test (Part
A and Part B) [22,23], initially included to examine visual
attention, psychomotor speed and cognitive flexibility,
was then eliminated because of general poor performance
and replaced with the Stroop Colour-Word test assessing
selective attention and cognitive flexibility [24]. The shor-
tened version of the Stroop test has been studied in an
Italian population [25]. Judgement and problem solving
ability was evaluated using Clinical Dementia Rating
(CDR) interview worksheets for patient and informant
[26,27].
Daily-life cognitive competence was assessed with the
Social Interactions section of the Spontaneous Behavior
Interview rating scale (SBI-SI) and the Informant Ques-
tionnaire on Cognitive Decline in the Elderly (IQCODE).
T h eS B Ii sam u l t i d i m e n s i o n a li n t e r v i e ww i t hap r o x y
informant used to measure the whole spectrum of demen-
tia symptoms in the everyday environment and consists of
three subscales assessing basic activities of daily living
(bADL), social interactions (SI), and behavioral distur-
bances (BD). Validity and reliability of the scale and its
sections have been previously investigated in a very large
number of subjects [28,29]. Inter-rater and test-retest reli-
abilities were excellent: r = 0.96 and r = 0.97 (n = 310),
respectively. The IQCODE rates changes in everyday cog-
nitive function based on informants’ reports. Mean global
score ranges between 1 (much better) and 5 (much worse)
[30,31]. When used retrospectively (on average 22 months
after death), the IQCODE was a valid instrument to iden-
tify cognitive impairment in subjects with neuropathologi-
cally defined Alzheimer’s disease [32].
The MMSE showed a very high correlation coefficient
with both SBI-SI (r = 0.85, p < 0.0001) and BIMC (r =
0.90, p < 0.0001). Thus, for individuals already deceased
or who could not be tested because of serious sensory
deficits, acute medical condition, or refusal, a MMSE
score was calculated (converted-MMSE) following a
method previously described [33,34]: the score on BIMC
or SBI-SI was converted to MMSE score applying the
formulas provided by regression analyses (MMSE = 2.78
+ [0.80 × BIMC] and MMSE = 28.10 - [0.87 × SBI-SI]).
A converted-MMSE (c-MMSE) score was calculated
also for individuals with advanced cognitive deteriora-
tion who were administered only the Severe MMSE.
Functional disability
The bADL section of the SBI assesses five domains of
basic self-care ADL: dressing, eating, walking, bathing
and continence. Scores range between 0 and 30, the low-
est indicating no degree of dependence [28,29]. The
Instrumental Activities of Daily Living scale (IADL)
investigates more complex daily tasks such as the ability
to use the telephone, prepare meals, handle finances, etc.
[35]. The scale covers eight activities for women and five
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cating the percentage of dependence: this new score
ranges between 0 and 100% for both men and women
with the lowest score indicating no degree of depen-
dence. IADL and SBI-bADL are instruments with very
high inter-rater and test-retest reliability [28,36] and have
been widely used in epidemiological and clinical trial
studies.
Behavioral disturbances
Nine common behavioral disturbances in dementia were
investigated by trained psychologists with the BD section
of SBI (SBI-BD): motor agitation, psychic agitation,
episodes of violence against things or people, getting lost,
episodes of nocturnal confusion, eating disorders, halluci-
nations, delusions, and sexual disinhibition [28,29]. Apathy
was evaluated in a different section of the SBI, while the
complex and variegated symptomatology of depression
was assessed with ad hoc instruments. SBI-BD assesses the
presence and frequency of behavioral disturbances during
the previous month on a scale from 0 (absent) to 3 (always
present), where each degree of frequency is clearly defined.
The total BD section score ranges from 0 to 27. Agree-
ment was high on items similarly investigated by the Neu-
ropsychiatric Inventory (NPI) and SBI-BD such as
delusions and hallucinations: respectively 0.90 and 0.94 for
the frequency of the behavior and 0.94 and 0.97 for the
presence of the behavior (n = 741 Alzheimer’sd i s e a s e
patients, authors’ unpublished data).
Mood
The Italian version of the Geriatric Depression Scale
(GDS) was devised to rate depression in the elderly
[37,38]. GDS-10 is a ten-item version highly correlated
with the original and showing good sensitivity and specifi-
city for significant depressive symptomatology with a cut-
off of 3/4 [39]. Scores range between 0 and 10 points, with
0 indicating absence of symptoms. When cognitive impair-
ment was apparent, the Cornell Scale for Depression in
Dementia (CSDD) was administered to subjects and/or
informants. Scores range between 0 and 38, higher scores
indicating more severe depressive symptomatology [40].
Training and quality control
Psychologists were recruited locally and followed a train-
ing course on each aspect of the research until they were
proficient in the standardized interview procedures. All
questionnaires completed were reviewed and discussed by
the study coordinators with each psychologist in weekly
meetings at the beginning of the study and then monthly.
The main common problems or field difficulties were dis-
cussed at monthly conferences. Even though test-retest
and inter-rater reliabilities of most instruments were
already known before the study started, agreement
between interviewers was evaluated at one of the study fol-
low-ups. During the first months of the survey the
feasibility of the questionnaire was tested and procedure
standardization was optimized. On the basis of this pilot
study, a few minor revisions of practical aspects of the
interview were introduced. Other small changes or supple-
mental material were introduced over the course of time.
Diagnosis
The diagnosis of dementia was made according to the cri-
teria of the Diagnostic and Statistical Manual of Mental
Disorders, fourth edition (criteria A, B, E, and F for Demen-
tia of the Alzheimer’s Type) [41]. At the end of each inter-
view, study psychologists described and evaluated the
cognitive status of the elderly person. Subsequently, each
study evaluator (a neurologist, a neuropsychologist, and a
psychologist) reviewed all the information collected and,
independently of the other evaluators, reached a prelimin-
ary diagnosis of dementia syndrome according to DSM IV
criteria. The degree of confidence was rated on a two-plus-
two decision scale: “dementia” and “probable dementia” on
one side, “probable no dementia” and “no cognitive impair-
ment” on the other. Degree of confidence reflects both the
evaluators’ subjective grading of the individual’s cognitive
functioning and the completeness and trustworthiness of
the information gathered for each subject. In the case of
disagreement, the experts reviewed all the data, discussed
initial diagnoses, and reached a final consensus. In case of
disagreement on the degree of confidence, the most pru-
dent rating ("probable”) was assigned. Diagnoses of demen-
tia made at a certain visit but not confirmed at subsequent
ones were reclassified as “non dementia” at that visit. The
global severity of dementia was staged in accordance with
the Clinical Dementia Rating (CDR) scale [26,27].
Based on all the information available including clini-
cal records and previous diagnosis present, the research
neurologists made an initial clinical diagnosis of the
dementia type for each subject they examined according
to DSM IV and other accepted diagnostic criteria. All
data will be reviewed and the preliminary diagnoses dis-
cussed by a panel of experts which will reach a final
diagnosis of dementia type.
Study procedures were in accordance with the principles
outlined in the Declaration of Helsinki of 1964 and follow-
ing amendments. The study protocol was submitted to
and approved by the Local Research Ethics Committee
(Azienda Sanitaria Locale of Varese Province). Psycholo-
gists and nurses or doctors obtained separate written
informed consents from all participants for data and blood
sample collections.
Laboratory methods
Fasting blood samples were collected by venipuncture
from consenting participants in a sitting position. Blood
and urine examination included routine investigations as
well as laboratory tests aimed at identifying potentially
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blood count, glucose, creatinine, total protein, protein
electrophoresis, AST, ALT, total cholesterol, HDL cho-
lesterol, triglycerides, sodium, potassium, calcium, vita-
min B12, folate, TSH, FT3, FT4, TPHA, and urine test).
Laboratory analyses were all done by Laboratorio Milano.
All blood donors consented to the storage of a blood
sample for studies of genetic epidemiology.
Statistical analysis
To describe the baseline status of the study sample we
tabulated the percentages (for nominal variables) and
means and standard deviations (for numerical variables) of
socioeconomic characteristics, life style habits, activities
and clinical features of the population. Cognitive, func-
tional, mood and behavior profiles were described using
both means and standard deviations and medians and
upper and lower quartiles so as to give a comprehensive
view of the distribution of the variables, particularly for
the ones that were not normally distributed. All character-
istics were tabulated in the overall sample and by quin-
quennia. Trend across (ordered) age groups was studied
using a test developed by Cuzick [42].
Characteristics derived from interview of the proxy
informants were compared between subjects alive at the
time of the study visit and subjects deceased after preva-
lence day but prior to the study visit by means of chi-
squared (for nominal variables) or Student’st - t e s t( f o r
numerical variables).
The correlation between cognitive performance and
daily life cognitive competence was calculated by means
of Pearson’s r linear coefficient.
E l d e r l ys u b j e c t sw i t ha n dw i t h o u tM M S Ew e r ec o m -
pared on a number of characteristics retrieved from the
interviews with proxy informants by means of chi-squared
(for nominal variables) or Student’s t-test (for numerical
variables). Comparisons were repeated to adjust for age,
sex and education using ANOVA.
Student’s t-test and Pearson’s linear correlation coeffi-
cient results were cross-checked with the non parametric
Mann-Whitney test and Spearman’s rank correlation
coefficient, respectively, finding very similar results (and
no change from significance to non significance or
viceversa).
Analyses were done using JMP v9.0.1 (Sas Institute
Inc., Cary, NC) and Stata/IC v11.1 (StataCorp, College
Station, TX).
Results
Study population
Figure 2 shows the flow diagram of the study. Of the
2,430 individuals 80 years or older registered in the
municipalities, 114 could not be traced. Among the 2,316
traced, 474 refused and 1,842 agreed to participate. A
parallel study with the GPs of the same population pro-
vided information, in an anonymous form (individuals
were identified only by age at prevalence day and sex), on
the medical history of a further 297 elderly persons
among those who refused or could not be found. Thus
2,139 individuals (88.0% of the registered population,
92.4% of the traced population) were included in the
main analyses. Since interviews of centenarians and those
of men 95-99 years old have just been concluded, data on
these individuals are not yet available for analyses and
are thus not reported in Figure 2 and the Tables. The
response rate in these age groups was very high as well
(95%).
Demographic characteristics of the entire population
and of participants and non-participants are reported in
Table 1. Percentage of women and mean age were very
similar between the original and the investigated popula-
tions (respectively: 73.9% and 74.1%, 87.2 and 87.3), but
a little lower in the small group of elderly for whom no
information was available (72.2% and 86.3). The percen-
tage of elderly persons who died in the year after the
interview or, for those without interview, after the pre-
valence day, was similar for the 2,430 residents (12.8%),
1,842 participants (12.8%) and 588 elderly persons with-
out interview (12.9%).
Socioeconomic characteristics, life style habits and
activities
Table 2 shows the socioeconomic characteristics of par-
ticipants and informants. As expected in an Italian
population of this age, the mean level of education was
low: about five years, corresponding to the completion
of elementary school. The education of the informants
was limited, but sensibly higher: it averaged more than
eight years, corresponding to the completion of lower
secondary school. The majority of the population (77%)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
llllllllllll 
 
 
 
 
 
 
Population in register: 2,430 
Participants:  1,842 
Not found: 114 
Refused: 474 
Individuals for whom 
information was available 
from their general 
practitioners: 297 
not included:
291 
 
Included at baseline:  2,139 
 
Population traced: 2,316 
Figure 2 Flow chart of the Monzino 80-plus Study.
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More than one third were living alone at least until age
95. The percentage of the oldest olds living in institu-
tions rose steeply with age, from 3.5% at age 80-84 to
more than a quarter over 94 years. About one in ten
elderly persons rated her/his economic condition as
“insufficient”. For more than three fourths of the com-
munity-dwelling elderly the informant was a family
member, either a spouse (12.4%) or a child (64.4%), and
in almost 20% another relative (Table 2). This explains
the relatively high mean age of the informants (more
than 60 years).
Life style habits and activities are reported in Table 3.
Not only were there few current smokers among the old-
est old (2.6%), but the percentage of former smokers was
also low (17.3%), a predictable consequence of the high
proportion of women who, as customary in this age group,
had never smoked (94% versus 39% among men). More
than a half of the population drank on average 1.5 glasses
of wine a day, with a higher prevalence among men (70%
drinking on average two glasses a day) than women (47%
drinking on average 1.5 glasses a day). More than 80% of
this population drank coffee, a very common habit in Italy,
with no appreciable sex differences. Physical activity, walk-
ing, hobbies, and social activities all decreased with age
but were more common among men than women.
Clinical characteristics
Table 4 shows the main clinical features of the popula-
tion by age group. Except for the prevalence of serious
hearing and visual impairments, which increased with
age, the frequency of most diseases peaked at earlier
ages. As expected, osteoarthrosis and cardiovascular dis-
eases were among the most prevalent clinical conditions.
More than one person in five reported a fall and almost
4% a bone fracture in the year preceding the interview.
During the same period, almost one third of the elderly
population was admitted to a hospital. Based on the
initial diagnoses, the preliminary estimate of over-eigh-
ties affected by dementia is rather high accounting for
about one third of the present study population (32%,
35% in women and 24% in men), with prevalence
increasing with advancing age (16% at 80-84 years, 34%
at 85-89, 43% at 90-94, and 57% over 94).
Table 1 Baseline demographic characteristics of the original population, the population included in the analyses, the
participants, and the group of elderly without information
Residents Individuals with information Participants Individuals without information
All, n 2,430 2,139 1,842 291
Men, n (%) 634 (26.1%) 553 (25.9%) 469 (25.5%) 81 (27.8%)
Women, n (%) 1,796 (73.9%) 1,586 (74.1%) 1,373 (74.5%) 210 (72.2%)
Mean age of men at interview (SD), years 86.9 (4.6)
1 87.2 (4.5)
Mean age of women at interview (SD), years 88.3 (4.8)
1 88.7 (4.7)
Mean age at interview, all (SD), years 88.0 (4.8)
1 88.4 (4.7)
Mean age at prevalence day, all (SD), years 87.2 (4.9) 87.3 (5.0) 87.6 (4.9) 86.3 (4.9)
2
Died in the year following interview,
3 % 12.8% n.a.
4 12.8% n.a.
4
1 At prevalence day for the individuals without interview;
2 Approximate estimates of the SD;
3 After prevalence day for those without interview;
4 The death rate
was 12.9% in the 588 individuals without interview (297 with and 291 without information).
Table 2 Baseline socioeconomic characteristics of participants and informants by age group
80-84 85-89 90-94 95+ All
n 542 581 569 150 1,842
Mean education (SD), years 5.5 (2.6) 4.9 (2.0) 5.1 (2.9) 4.7 (2.4) 5.1 (2.5)
Main occupation
1,%
manual workers 76.3 81.4 69.9 77.9 76.0
crafts and trades 11.3 10.8 16.3 11.0 12.7
professionals and clerks 11.7 6.6 11.9 8.3 9.9
Living alone,% 37.5 38.0 35.3 19.8 35.8
Living in institutions, % 3.5 10.9 16.3 26.0 11.6
Economic condition, insufficient, % 8.4 14.4 7.3 13.3 10.4
Home ownership, % 94.4 91.9 92.2 93.9 92.9
Principal informant, child or spouse, % 80.3 76.1 75.2 75.4 76.8
Informants’ mean age (SD), years 61.4 (13.7) 59.6 (11.1) 61.6 (9.6) 64.4 (9.8) 61.1 (11.3)
Informants’ mean education (SD), years 8.1 (3.7) 8.5 (3.9) 8.9 (3.9) 8.7 (3.8) 8.5 (3.9)
1 Organizing the major groups of the International Standard Classification of Occupations (ISCO-08) in three classes.
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Page 7 of 14Cognitive, functional, mood, and behavioral assessments
Cognitive performance, cognitive competence and
functional abilities decreased steadily with age (Table
5). Instead, depressive symptoms and behavioral distur-
bances did not show substantial variations with age.
Global cognitive performance (MMSE or converted-
MMSE) was highly correlated with daily-life cognitive
competence ratings: Pearson’s linear correlation coeffi-
cient - 0.82 and - 0.85 with IQCODE; - 0.85 and - 0.94
with SBI-SI. The accuracy of the formulas provided by
regression analyses to estimate a c-MMSE score in
individuals who did not perform the test was empiri-
cally tested in the sub-population of oldest old for
whom the actual scores of MMSE and BIMC or of
MMSE and SBI-SI were available. In the 1,268 indivi-
d u a l sw i t hb o t hb a s e l i n eM M S Ea n dS B I - S Is c o r e s
available, the mean MMSE score was 22.44 (SD 7.37)
and the mean estimated c-MMSE score was 22.90 (SD
6.45). In the 161 individuals with both MMSE and
BIMC scores available, the mean MMSE score was
17.81 (SD 7.10) and the mean estimated c-MMSE
score was 17.99 (SD 6.07).
Comparison of elderly with and without MMSE
Elderly persons alive at baseline without MMSE had sig-
nificantly worse cognitive competence and functional
ability, and reported higher prevalences of depressive
symptoms and problem behaviors than elderly with
MMSE (all p values < 0.0001) (Table 6). The percen-
t a g e so fe l d e r l yp e r s o n sw i t h o u tM M S Er o s er a t h e r
evenly with age (p < 0.0001) (Table 6).
Comparison of alive elderly and those who died
Table 7 shows the main baseline characteristics of living
elderly persons and of those who died between the pre-
valence day and the first visit for whom information was
available. On average, informants were interviewed
about ten months after the individual’sd e a t h .I n
Table 3 Life style habits and activities of participants (n = 1,842) by age group at baseline
80-84 85-89 90-94 95+ All Men Women
Current smoker, % 3.7 2.9 1.6 0.7 2.6 6.2 1.3
Former smoker, % 26.3 15.6 12.3 10.7 17.3 54.4 4.6
Current alcohol consumption, % 58.5 52.7 51.2 39.3 52.8 69.9 47.0
Former alcohol consumption, % 12.2 16.8 16.0 22.0 15.6 17.7 14.9
Mean current daily alcohol, cl (SD)
1 17.3 (12.3) 18.2 (15.5) 14.9 (10.8) 15.4 (12.5) 16.7 (13.0) 23.3 (15.7) 13.4 (9.8)
Mean former daily alcohol, cl (SD)
1 25.9 (34.3) 18.8 (21.3) 14.2 (12.1) 21.5 (32.0) 19.2 (24.4) 28.8 (35.9) 15.3 (16.2)
Coffee drinking, % 81.6 83.2 78.7 78.8 81.0 82.1 80.6
Physical activity, % 53.8 35.5 25.0 16.0 36.0 49.3 31.5
Walking, % 87.4 77.1 63.3 51.0 73.7 79.7 71.7
Hobbies, % 79.2 67.5 53.4 39.2 64.3 74.4 60.8
Social activity, % 48.2 37.0 20.8 12.6 33.3 35.7 32.5
1 About 12 cl in one glass of wine.
Table 4 Main clinical features of the population with available information (n = 2,139) by age group at baseline
80-84 85-89 90-94 95+ All
n 691 653 632 163 2139
Hypertension, % 58.2 57.7 56.0 49.7 56.7
Diabetes, % 15.3 12.3 13.0 9.3 13.2
Myocardial infarction, % 8.8 7.0 7.5 4.6 7.5
Heart failure, % 22.3 27.8 30.6 29.4 27.0
Chronic obstructive pulmonary disease, % 14.7 19.8 19.2 15.5 17.7
Stroke, % 10.5 14.5 13.1 15.5 12.9
Serious hearing impairment, % 1.9 6.4 9.0 14.7 6.3
Serious visual impairment, % 3.3 5.8 8.5 14.7 6.5
Osteoarthrosis, % 64.9 63.6 70.7 68.3 66.5
Hospital admission in previous year, % 35.4 32.1 30.4 26.2 32.1
Drug use, % 85.2 90.6 91.4 90.5 89.1
Mean number of drugs among users, (SD) 3.1 (1.7) 3.5 (2.0) 3.5 (2.0) 3.3 (1.9) 3.4 (1.9)
Cholinesterase inhibitors, % users 1.6 1.4 0.5 0.0 1.1
Nootropics, % users 0.3 1.5 1.9 1.3 1.2
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Page 8 of 14comparison with those living, elderly persons who were
already dead at the time of the first visit were older, had
twice the rate of institutionalization, lower cognitive
competence, and significantly higher instrumental and
basic functional disability.
Discussion
Until recently, relatively few data have been available on
the epidemiology of dementia in the oldest old [5],
despite its being the fastest growing age group and the
most cognitively impaired one.
Table 5 Mean (SD) and median (25th-75th percentiles) baseline cognitive, functional, mood, and problem behavior
scores by age group
n 80-84 85-89 90-94 95+ All
Mini-Mental State Examination (MMSE) or converted-MMSE 1842 24.6 (6.5) 21.3 (7.4) 19.7 (7.9) 16.3 (8.1) 21.4 (7.8)
27 (24-28) 24 (17-27) 22 (14-26) 17 (10-24) 24 (17-27)
Mini-Mental State Examination 1268 25.5 (5.7) 22.0 (7.0) 20.6 (7.7) 16.8 (8.6) 22.4 (7.4)
27 (25-29) 24 (19-27) 23 (16-26) 18 (11-24) 25 (20-28)
Blessed-Information Memory Concentration test
1 37 15.8 (4.3) 12.7 (6.7) 10.4 (5.3) 10.0 (5.7) 12.4 (6.2)
16 (12-20) 10 (8-17) 10 (5-13) 10 (6-14) 10 (8-16)
Severe Mini-Mental State Examination
1 11 - 21.4 (7.6) 11.2 (4.0) - 15.8 (7.7)
- 24 (14-28) 12 (8-15) - 14 (9-24)
Informant Questionnaire on Cognitive Decline in the Elderly 1664 3.5 (0.6) 3.8 (0.7) 4.0 (0.8) 4.3 (0.7) 3.8 (0.8)
3.2 (3-3.8) 3.6 (3.2-4.6) 4.0 (3.3-5) 4.4 (3.5-5) 3.6 (3.2-4.6)
Spontaneous Behavior Interview-Social Interaction 1829 4.7 (7.7) 8.1 (9.0) 10.2 (9.6) 13.3 (10.2) 8.1 (9.3)
1 (0-5) 4 (1-13) 7 (2-16) 12 (5-20) 4 (1-13)
Spontaneous Behavior Interview-basic activities of daily living 1836 3.9 (7.3) 6.9 (8.5) 9.8 (9.6) 14.3 (9.7) 7.5 (9.1)
0 (0-4) 4 (0-12) 6 (1-18) 15 (6-22) 3 (0-13)
Instrumental Activities of Daily Living, % disability 1829 29.6 (33.2) 49.7 (35.0) 60.7 (35.1) 77.9 (28.4) 49.5 (37.1)
18 (0-42) 42 (20-88) 66 (27-97) 94 (63-100) 42 (17-93)
Geriatric Depression Scale-10 items
2 1406 2.0 (2.5) 2.9 (2.7) 2.9 (2.7) 2.8 (2.6) 2.6 (2.7)
1 (0-3) 2 (1-4) 2 (1-5) 2 (1-5) 2 (0-4)
Spontaneous Behavior Interview-Behavioral Problems 1822 0.7 (2.0) 1.4 (2.7) 1.1 (2.5) 1.0 (2.0) 1.1 (2.4)
0 (0-0) 0 (0-2) 0 (0-1) 0 (0-1) 0 (0-1)
1 Individuals without MMSE;
2 Individuals with a possible or manifest cognitive impairment were administered the Cornell Scale for Depression in Dementia (n =
716).
Table 6 Baseline characteristics of living individuals with MMSE or c-MMSE scores
Individuals with MMSE Individuals with c-MMSE p-value
1
Age group, years, % (n)
80-84 77.0% (418) 23.0% (125) < 0.0001
85-89 70.5% (409) 29.5% (171)
90-94 62.4% (355) 37.6% (214)
95+ 57.3% (86) 42.7% (64)
All, % (n = 1,842) 68.8% (1,268) 31.2% (574)
with BIMC or SMMSE but no MMSE, n 48
Education, mean (SD) 5.3 (2.6) 4.7 (2.4) < 0.0001
Living in institution, % (n) 9.9% (126) 15.3% (88) 0.0007
MMSE or c-MMSE, mean (SD) 22.4 (7.4) 18.7 (8.0) < 0.0001
2
IQCODE, mean (SD) 3.7 (0.7) 4.1 (0.8) < 0.0001
2
Spontaneous Behavior Interview-SI, mean (SD) 6.5 (8.2) 12.0 (10.4) < 0.0001
2
Spontaneous Behavior Interview-bADL, mean (SD) 5.5 (7.8) 11.9 (10.4) < 0.0001
2
IADL, mean % disability (SD) 42.0 (35.6) 66.0 (35.1) < 0.0001
2
Geriatric Depression Scale-10, mean (SD) 2.3 (2.4) 4.0 (3.2) < 0.0001
2
Spontaneous Behavior Interview-BP, mean (SD) 0.9 (2.1) 1.8 (3.1) < 0.0001
2
BIMC: Blessed Information Memory Concentration test; SMMSE: severe Mini-Mental State Examination; c-MMSE: converted-MMSE; IQCODE: Informant
Questionnaire on Cognitive Decline in the Elderly; SI: Social Interaction; bADL: basic Activities of Daily Living; IADL: Instrumental Activities of Daily Living; BP:
Behavioral Problems.
1Student’s t-test for numerical variables, chi-squared for nominal variables.
2Both univariate and adjusted for age, sex and education.
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Page 9 of 14Most of the numerous population-based studies on cog-
nitive impairment and dementia have included a broad
age span of elderly persons (commonly 65 years or older)
with the consequence that the number of oldest old inves-
tigated has usually been too small to accurately estimate
the prevalence and incidence of dementia in this segment
of the elderly population. Even when the number of oldest
old included was large enough [43-53], extreme ages were
often poorly represented. To overcome this limitation and
more reliably investigate the relationship between age and
dementia in the advanced ages, a few studies have focused
on the oldest old. All available inhabitants aged 85 years
or older (n = 891; 95+ years = 34) were included in the
“Leiden 85 plus study” [54]. A random sample of 358 citi-
zens aged 85 years and over (90+ years = 91) was assessed
in the Munich study [55]. Prevalence and severity of
dementia was investigated in two birth cohorts of 494 85-
year-old and 338 95-year-old persons born in Göteborg
[56,57]. The Vantaa 85+ Study included all available per-
sons of at least 85 years of age (n = 553; 90+ years: 105
out of 399 deceased individuals) but only the overall point
prevalence of dementia was reported [58]. Survivors aged
90 and older (n = 911) from the Leisure World Cohort
Study, a retirement community in California, were
enrolled in the 90+ Study [59]. Information on these
populations of oldest old was mostly limited to some
demographic characteristics while no or very few data on
general health status, life style habits, functional disability,
and behavioral disturbances have yet been reported.
Conducting studies in the oldest old is of course much
more problematic than in the younger old. Assessing
and monitoring cognitive behavior in a population with
high morbidity and disability is challenging: many die,
many are in critical condition or seriously ill, have
severe sensory or language deficits, are easily fatigued,
or do not cooperate. Moreover, feeling vulnerable and
defenceless makes the very old and their relatives more
hesitant to agree to participate in research studies. In
consideration of this complexity, our initial choice to
conduct almost all of the aspects of the research at the
elderly’s place of residence proved successful. This was
confirmed by the widespread unwillingness of the
elderly with dementia to carry out a brain imaging study
to assist in the differential diagnosis of dementia type.
Relying on a large array of diverse tools to assess the
multifaceted manifestations of dementia has also proved
successful. Informant-based assessment instruments of
cognitive behavior such as SBI-SI and IQCODE not only
showed less attrition than measures that required testing
the individual [60]; because of their very high correlation
with measures of cognitive performance, it was also pos-
sible to evaluate individuals who could not or refused to
be tested and thus compare the cognitive functioning
and change in this group to that of the testable elderly.
Habits, health status and the risk of cognitive decline
Despite the poor health of many elderly persons, more
than one third of this population of oldest old were liv-
ing alone, though in several cases in close contact with
children and relatives. The frequency of most diseases
did not continue to rise at the extreme ages, suggesting
that those who reach advanced years (for the most part
Table 7 Baseline characteristics of the elderly alive at first visit and those who died between the prevalence day and
first visit
Alive Dead p value
1
All (1,842), n (%) 1688 (91.6%) 154 (8.4%)
Men, n (%) 427 (91.0%) 42 (9.0%) 0.5899
Women, n (%) 1261 (91.8%) 112 (8.2%)
Age, mean (SD) 88.2 (4.6) 89.5 (5.2) 0.0036
Age group, years, (%) 0.0059
80-84 93.5 6.5
85-89 92.9 7.1
90-94 90.0 10.0
95+ 86.0 14.0
Education, years, mean (SD) 5.1 (2.6) 5.0 (2.1) 0.3019
Living in institutions, % 10.7% 21.4% <0.0001
Mini-Mental State Examination (MMSE) or c-MMSE, mean (SD) 21.5 (7.7) 19.9 (8.4) 0.0290
Spontaneous Behavior Interview (SBI)-Social Interactions, mean (SD) 7.9 (9.2) 10.4 (10.8) 0.0064
Informant Questionnaire on Cognitive Decline in the Elderly, mean (SD) 3.8 (0.7) 4.0 (0.8) 0.0029
Instrumental Activities of Daily Living, mean % disability 48.1 (37.0) 64.9 (35.4) <0.0001
SBI-basic Activities of Daily Living, mean (SD) 7.1 (8.9) 12.0 (10.3) <0.0001
SBI-Behavioral Problems, mean (SD) 1.1 (2.4) 1.0 (2.5) 0.6981
c-MMSE: converted-MMSE; SBI: Spontaneous Behavior Interview.
1 Student’s t-test for numerical variables, chi-squared for nominal variables.
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Page 10 of 14women) might be a select and particular group. How-
ever, cognitive performance and competence as well as
instrumental and basic activities of daily living all stea-
dily decline with age.
Lifestyle habits like smoking and, to a lesser degree,
alcohol and coffee consumption also tended to decrease
with age. Though a small percentage of oldest men were
still smoking, more than half were former smokers, while
only a small fraction of the oldest women had ever
smoked. Behaviors deemed to be protective like physical
and social activities and hobbies also tended to decrease
with age. It is of note that in the face of the loss of cogni-
tive and functional abilities, the prevalence of putative
risk factors for cognition like diabetes declines with age.
This seems to suggest that other age-related factors
would intervene, negatively affecting the brain and that
different pathogenetic mechanisms could be involved in
dementia onset depending on age.
Cognitive performance in the oldest old
In the present study population performance on the
MMSE steadily decreased with increasing age (Table 5).
Using the same standardized version and administration
and scoring procedures of the MMSE in a population of
1,680 cognitively normal overeighties from four Italian
communities (mean education: 6.2 years), we found that
the mean MMSE score declined slowly with increasing
age: 26.9 at age 80-84, 25.7 at age 85-89, 25.2 at age 90-
94, and 24.4 at age 95 and over (unpublished data). Dif-
ference in mean MMSE score between this cognitively
normal population and the present study general popula-
tion (Table 5) progressively increased with increasing age
(1.4 at age 80-84, 3.7 at age 85-89, 4.6 at age 90-94, and
7.6 at 95 and over) strongly suggesting that in the general
population the proportion of oldest old with cognitive
impairment rises with age. Mean MMSE score in the pre-
sent study population was consistently lower also com-
p a r e dt ot h a to fo t h e rp o p u l a t i o n sw i t hah i g h e r
educational level. Without considering possible item var-
iations and different administration and scoring proce-
dures of MMSE in the diverse studies, the mean MMSE
score of the present study population was 22.4 (n =
1,268; 0-8 years of education: 93.1%) versus 24.6 in the
80 years or older individuals of five US community popu-
lations (n = 951; 0-8 years of education: 56.9%) [61] and
23.9 in the 80 years or older individuals of the Kungshol-
men Project (n = 1,067; 0-7 years of education: 26.4%)
[62]. In a sample of 435 adults aged 90 or older enrolled
in the 90+ Study, a well-educated, upper middle class
cohort, the mean MMSE score was 22.2 (0-12 years of
education: 26.7%) [63] versus 19.9 in the 90 and older
individuals of the present study (n = 441, 0-12 years of
education: 95.7%). The two Göteborg cohorts had a
higher proportion of elderly with a low educational level
(0-6 years: 75% in the 85-year-old cohort and 67% in the
95-year-old cohort) and their mean MMSE scores (~23.5
in the 85-year-old cohort and ~18.1 in the 95-year-old
cohort) were similar to those of the individuals of the
same age in the present study (85-year-old: 23.4; 95-year-
old: 18.5) [56,57]. These results suggest that the compari-
son of prevalence and incidence rates of dementia
between populations with quite different educational
levels could represent an interesting model to investigate
the actual and still controversial role of formal education
in cognitive decline and in the development of dementia
and Alzheimer’s disease.
Failing to consider the deceased or untested individuals
results in bias
The results reported in Tables 6 and 7 have noteworthy
implications. The lack of MMSE does not appear to be a
random, innocent occurrence. Subjects alive and without
MMSE are clearly older, more often institutionalized, and
have much worse cognitive, functional, and behavioral
profiles than those with MMSE. Hence the importance of
also measuring observable behaviors in the everyday
environment to gather more complete and reliable infor-
mation in a field survey on the very old. Collateral
sources, usually the spouse or an adult child, were shown
to be accurate in reporting the cognitive abilities of sub-
jects even in a very mild stage of dementia [64,65]. More-
over, informant-based instruments help establish the
relevance of current deficits in cognitive tests to everyday
functioning and assess change from the pre-morbid level
or from a previous disease stage. This longitudinal
approach proved to be a valid aid in the diagnostic
process.
Shorter survival is associated with a higher level of cog-
nitive impairment [66]. Dementia shortens life expectancy
[67], even in the oldest old [68-71]. This differential mor-
tality between demented and non-demented elderly can
influence prevalence and incidence estimates of dementia
[72,73] and cognitive impairment [74], particularly among
the oldest old. What emerges from comparisons of the
demographic and clinical characteristics of individuals still
alive versus those who had died at the time of the first
visit (Table 7) is that the failure to include information on
deceased elderly would increasingly underestimate with
age the prevalence of cognitive and functional disability in
the elderly population. Retrospective interviews (on aver-
age two years after death) were shown to be sensitive
instruments to detect the antemortem presence of demen-
tia and were strongly associated with late-life MMSE
scores taken close to death [32,75,76]. In the attempt to
limit the attrition bias due to the expected high mortality
rate and differential survival rates, a great effort was made
at follow-ups to gather complete information also on par-
ticipants who had died between two subsequent visits.
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The Monzino-80 Plus is one of the largest prospective
population-based studies specifically aimed at thoroughly
investigating cognitive decline and dementia in the very
old. The large number of individuals investigated also at
extreme ages, the high response rate, one-phase design,
extensive baseline information collected with standardized
and reliable instruments, and close attention to keeping
the population representative over time should provide
more accurate estimates of the occurrence of dementia in
the oldest ages and contribute significantly to understand-
ing the complex, heterogeneous basis of cognitive decline
and dementia. Failure to take deceased or untested indivi-
duals into consideration could affect the accuracy of the
estimates of prevalence of cognitive and functional
disability.
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